Updated:
Brandon Capital Partners
Brandon Capital Partners is a Melbourne-based private equity firm focused on early-stage and growth investments.
Brandon Capital Partners
Brandon Capital is Australasia's leading life science venture capital firm, with a strong global presence supported by key partnerships and team members across the US and UK. Through collaboration and investment, we transform promising medical research breakthroughs into medical therapies that improve patients lives. We have supported more than 50 start-up companies to date, the majority of which were founded by us in collaboration with the inventor and their research institutes.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Oceania
Country
Australia
City
Melbourne
Corporate office
Melbourne, Australia
Sector focus
Frequently asked questions
Who runs investment decisions at Brandon Capital Partners?
No named principals or investment committee members are disclosed in available records.
How does Brandon Capital Partners source proprietary deal flow?
No sourcing model or network details are provided in source material.
Does Brandon Capital Partners participate in fund commitments or only direct deals?
The firm description indicates direct private equity activity but provides no breakdown of fund versus direct exposure.
What investment stages does Brandon Capital Partners typically target?
The firm targets early stage seed, start-up, expansion, late stage, and growth opportunities.
Where does the underlying capital originate?
No wealth origin or LP composition is disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: